Mouse Allergy Shots: Urban Infestation, Mus m 1, and Inner-City Asthma
Mouse allergy is two stories: urban infestation (Mus m 1 in >75% of inner-city homes) driving pediatric asthma that rivals cockroach, and laboratory animal allergy affecting atopic workers within months. Mus m 1 — a 19 kDa lipocalin produced 4x more in male mice — sensitizes >90% of mouse-allergic individuals. No FDA-standardized extract exists.
Mouse Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to mouse — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of mouse allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of mouse immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of mouse extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for mouse allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing mouse extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription mouse immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat mouse allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Mouse?
The biology, taxonomy, and clinical fingerprint of Mouse — the foundation of how SCIT targets it.
Individually ventilated cages (IVCs) reduce ambient room Mus m 1 levels in labs but paradoxically increase cage-change exposure. Inner-city homes: mouse urine on subfloors, wall voids, and stored cardboard are invisible allergen reservoirs — patients often don't know they are exposed.
- Scientific name
- Mus musculus
- Family
- MuridaeMouse and rat family
- Type
- Urban infestation and laboratory animal allergen
- Native to
- Central Asia; commensal global distribution tracking human habitation
- Allergen proteins
- Mus m 1 (major) — 19 kDa major urinary protein (MUP) lipocalin; >90% sensitization; 4× higher production in males due to testosterone-dependent hepatic synthesisMus m 2 — 16 kDa glycoprotein; found in hair and dander, NOT urine; minor allergenMouse serum albumin — ~67 kDa; sensitizes ~30% of mouse-allergic individuals; cross-reactive with mammalian albumin family
- Particle size
- Mus m 1 in urine aerosolizes as submicron particles; airborne concentrations 0.5-563 ng/m^3 in animal facilities depending on task
- Avoidance difficulty
- Very difficult
How Mouse Allergy Presents
Symptoms by body system — useful for distinguishing Mouse sensitivity from overlapping allergies and infections.
Respiratory
- Perennial rhinitis in inner-city homes with mouse infestation — often mistaken for seasonal or dust-mite allergy
- Asthma exacerbations correlated with Mus m 1 levels in the child's bedroom and living areas
- Cough and bronchospasm most pronounced in the mornings — peak urine aerosolization from overnight mouse activity
- Occupational asthma in laboratory workers progressing from rhinitis (mean 7 months to onset)
- Asthma severity in inner-city pediatric populations significantly associated with mouse allergen sensitization (Phipatanakul et al. body of work)
Ocular
- Conjunctivitis during and after cage-cleaning tasks in laboratory workers
- Eye itching in household members where mouse infestation is present
- Periorbital redness in heavily sensitized children in high-infestation housing
- Ocular symptoms accompanying nasal symptoms in sensitized individuals
Dermal
- Contact urticaria at mouse bite or scratch sites in laboratory workers
- Hive formation after handling mice in research or pest-control contexts
- Atopic dermatitis flare in sensitized children in high-infestation environments
- Skin sensitization rare in household infestation settings given primarily airborne allergen route
Systemic
- Chronic fatigue and sleep disruption from poorly controlled nocturnal rhinitis and asthma
- Occupational disability with career disruption in laboratory workers who develop occupational asthma
- Persistent systemic inflammation from high Mus m 1 exposure in poorly remediated urban housing
- Pediatric school performance impact from unrecognized chronic mouse allergen exposure at home
Mouse is the allergen that flipped the inner-city asthma story over the past 20 years. We used to attribute everything to cockroach, and then mouse came up the rankings — sometimes higher than cockroach in homes with infestation. The challenge is that patients often don't know they're exposed: mouse urine on subfloors, in wall voids, in stored cardboard. We confirm with Mus m 1 IgE and then talk about pest management before we talk about immunotherapy.
Where Mouse Triggers Year-Round
Mouse is a perennial trigger — exposure is constant for sensitized patients. Geographic intensity still varies by climate.
12-Month Intensity
Year-roundPerennial year-round; modest increase in fall and winter when mice seek indoor shelter, increasing infestation density in residential buildings.· Year-round for laboratory workers and infested homes; fall-winter increase for new infestations in residential settings.
US Exposure Map
20 high-intensity statesWhat Mouse Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Mus m 1 sits in the center of the rodent lipocalin cross-reactivity network — sharing 60-80% sequence homology with rat Rat n 1 and meaningful homology with guinea pig, horse, cat, and dog lipocalins.
Mus m 1 ↔ Rat n 1: 60-80% sequence homology — the closest cross-reactive pair in animal allergy; most rodent-sensitized patients are co-sensitized (Jeal et al., Allergy 2009)
Is SCIT Right for Your Mouse Allergy?
Answer five questions to assess whether mouse allergy shots are appropriate for your situation — urban infestation, laboratory worker, or pet mouse owner each has a different clinical path.
How severe are your mouse allergy symptoms?
The Mouse SCIT Protocol
Mouse SCIT uses non-FDA-standardized epithelial or urine-based extract. Successful integrated pest management (IPM) should be confirmed before or concurrent with starting SCIT — ongoing high infestation levels during immunotherapy reduce the likelihood of clinical benefit.
Standard inhalant SCIT build-up from diluted starting concentrations. For laboratory workers, NIOSH 97-116 engineering controls (IVCs, HEPA filtration, 10-15 air changes/hour, directional airflow, corncob bedding, N95 during cage changes) should be in place concurrently. For urban infestation patients, IPM should be confirmed effective before starting. 30-minute post-injection observation is mandatory.
Maintenance injections continue alongside allergen source reduction. Because Mus m 1 ↔ Rat n 1 cross-reactivity is 60-80%, single-allergen mouse SCIT may provide partial rat coverage in co-exposed patients. Component-resolved diagnostics (Mus m 1 vs Rat n 1) confirms the primary sensitizer. Regular clinical monitoring for patients with comorbid asthma.
Discontinuation may be appropriate when occupational role changes or successful long-term pest remediation eliminates ongoing high-level exposure. For laboratory workers who remain in mouse-handling roles, extended maintenance may be warranted.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Mouse SCIT
No double-blind placebo-controlled RCT for mouse SCIT specifically has been published. Evidence is derived from LAA occupational worker cohorts and from inner-city asthma research demonstrating the critical role of Mus m 1 allergen reduction in asthma control.
- Mus m 1 IgE sensitization rate in mouse-allergic individuals90%Múnera CM et al., Immunol Lett 2019; Ferrari E et al., Int J Mol Sci 2023
- Inner-city homes with clinically significant mouse allergen levels75%NIEHS-funded inner-city asthma research; Phipatanakul W et al., multiple publications
No DBPC-RCT for mouse SCIT is available. The most important evidence-based intervention for mouse allergy — particularly in the inner-city pediatric asthma context — is integrated pest management producing confirmed Mus m 1 allergen load reduction, combined with HEPA air filtration. SCIT for laboratory workers with confirmed Mus m 1 sensitization is extrapolated from the general AAAAI/ACAAI Practice Parameter framework and from LAA cohort data showing that atopic workers progress from rhinitis to asthma with continued high-level exposure, providing biological rationale for immunotherapy.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Mouse SCIT Side Effects
Mouse SCIT side effects follow the general inhalant SCIT profile. For inner-city patients where cockroach co-sensitization is common, multi-allergen formulations may be more appropriate than single-allergen mouse extract.
Local reactions
4 documentedSystemic reactions
4 documentedTraditionally SCIT was given only in a clinic, but for eligible maintenance patients Curex makes safe at-home self-administration possible: a personalized serum sterile-compounded to USP <797> and lot-tested, a prescribed epinephrine auto-injector confirmed on hand before the first injection, and the first dose plus every dose change supervised live over Zoom by the prescribing allergist. For pediatric patients with mouse-allergy-driven asthma, pre-injection spirometry to confirm FEV1 >70% predicted is standard practice, and reactions typically begin within ~30 minutes, so a brief post-injection self-observation is advised.
SCIT vs Alternatives for Mouse
For infestation-related mouse allergy, integrated pest management (IPM) is the most evidence-supported first intervention. For laboratory workers, NIOSH 97-116 controls are first-line. SCIT and SLIT are secondary options after source reduction.
| Criterion | SCITBest | SLIT | IPM (infestation) | Medications + HEPA |
|---|---|---|---|---|
| Effectiveness | Limited — no RCT; LAA cohort rationale | Off-label; less evidence than occupational SCIT | Significant allergen reduction when effective | Partial — manages symptoms, not sensitization |
| 5-yr cost | $3,500-$10,000 | $129/month | Variable (remediation costs) | $500-$2,000/yr + HEPA cost |
| Duration | 3-5 years | 3-5 years | Permanent when successful | Indefinite |
| Convenience | Self-administered weekly at home with Curex (build-up) | Daily drops at home | Structural home modification may be required | Daily medications + equipment |
| Safety | Very safe; Curex confirms prescribed epinephrine on hand and supervises your first dose and every dose change live over Zoom | Very safe; no clinic required | No medical side effects | Generally safe |
| Lasting effect | Some sustained benefit post-course | Ongoing benefit while continuing | Permanent if maintained | No lasting effect after stopping meds |
SCITBest
SLIT
IPM (infestation)
Medications + HEPA
For inner-city pediatric mouse allergy, the most evidence-based path is IPM to reduce Mus m 1 load combined with HEPA air filtration, then reassessment. For laboratory workers whose occupational exposure persists despite engineering controls, SCIT provides the best available immune-modifying approach. A board-certified allergist can confirm Mus m 1 sensitization in inner-city households, and Curex delivers that same SCIT as a weekly shot you give yourself at home for $129/month — a personalized serum sterile-compounded to USP <797> and lot-tested, a prescribed epinephrine auto-injector confirmed on hand before the first injection, and the first dose plus every dose change supervised live over Zoom by the prescribing allergist, with a prescribed epinephrine auto-injector confirmed on hand — a needle-free-of-clinic-trips option for shift-working laboratory technicians who cannot maintain weekly clinic schedules.
What Mouse SCIT Actually Costs
Most major US health insurers cover occupational allergen SCIT under standard allergy benefits when prescribed by a board-certified allergist with documented IgE sensitization. Coverage for infestation-related mouse allergy SCIT may vary; documentation of confirmed Mus m 1 sensitization and failed environmental management strengthens coverage applications. Out-of-pocket costs depend on deductible and co-insurance structure. Curex at-home IgE testing identifies specific mouse sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your mouse allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Mouse SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Both mouse and dust mite are perennial indoor allergens strongly associated with pediatric asthma, but they are molecularly distinct and geographically distributed differently. Dust mite allergens (Der p 1, Der f 1 — serine proteases) dominate in humid coastal cities and suburban homes. Mouse allergen (Mus m 1 — lipocalin) dominates in dense urban housing with infestation, particularly in the Midwest and Northeast. Research from Phipatanakul and colleagues showed that in some inner-city cohorts, mouse sensitization was more strongly associated with asthma severity than cockroach or dust mite. The management approaches also differ: dust mite requires mattress encasements and humidity control; mouse requires integrated pest management (sealing entry points, trapping, food storage). Component-resolved testing identifying Mus m 1 vs Der p 1/Der f 1 IgE helps direct the correct environmental intervention.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.